A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.
Lim KJC, Steinhardt M, Rees MJ, Greipp P, Kelemen K, Dispenzieri A, Jevremovic D, Baughn L, Buadi FK, Dingli D, Hayman SR, Kapoor P, Muchtar E, Leung N, Fonder A, Hobbs M, Hwa YL, Warsame R, Kourelis TV, Cook J, Binder M, Abdallah N, Zanwar S, Lin Y, Go RS, Siddiqui MA, Parrondo RD, Ailawadi S, Roy V, Cooke R, Dun K, Zordan A, Ninkovic S, Best SH, Alatorre GA, Wiedmeier-Nutor JE, Kortum KM, Einsele H, Chhabra S, Bergsagel PL, Kyle RA, Gertz MA, Kumar SK, Rajkumar SV, Fonseca R, Gonsalves WI, Yadav U.
Lim KJC, et al.
Blood Adv. 2026 Jun 23;10(12):4286-4295. doi: 10.1182/bloodadvances.2025019136.
Blood Adv. 2026.
PMID: 42018661
Free PMC article.